Citation Impact
Citing Papers
A self-assembling peptide acting as an immune adjuvant
2009
The Adjuvants Aluminum Hydroxide and MF59 Induce Monocyte and Granulocyte Chemoattractants and Enhance Monocyte Differentiation toward Dendritic Cells
2008
Controlling timing and location in vaccines
2020
Messenger RNA expressing PfCSP induces functional, protective immune responses against malaria in mice
2021 StandoutNobel
A Synthetic Adjuvant to Enhance and Expand Immune Responses to Influenza Vaccines
2010
Intracellular Delivery System for Antibody–Peptide Drug Conjugates
2015 StandoutNobel
Effect of Zeta Potential on the Properties of Nano-Drug Delivery Systems - A Review (Part 2)
2013 Standout
Engineering precision nanoparticles for drug delivery
2020 Standout
Biomimetic nanoparticles: preparation, characterization and biomedical applications
2010
Dendritic cells in cancer immunology and immunotherapy
2019 Standout
Pathogen recognition and development of particulate vaccines: Does size matter?
2006
Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns
2010 Standout
Materials engineering for immunomodulation
2009 Nature
Charged nanoparticles as protein delivery systems: A feasibility study using lysozyme as model protein
2007
Adjuvant-carrying synthetic vaccine particles augment the immune response to encapsulated antigen and exhibit strong local immune activation without inducing systemic cytokine release
2014
Effect of Immunosuppression on T-Helper 2 and B-Cell Responses to Influenza Vaccination
2015 StandoutNobel
The role of liposomes in clinical nanomedicine development. What now? Now what?
2019 Standout
The perfect mix: recent progress in adjuvant research
2007
MF59 Emulsion Is an Effective Delivery System for a Synthetic TLR4 Agonist (E6020)
2009
Programming the magnitude and persistence of antibody responses with innate immunity
2011 Nature
Nanoparticle Vaccines Against Infectious Diseases
2018
Poly‐Lactic Acid: Production, Applications, Nanocomposites, and Release Studies
2010 Standout
Molecular mechanisms regulating NLRP3 inflammasome activation
2015 Standout
PLGA-based nanoparticles: An overview of biomedical applications
2012 Standout
Superior immunogenicity of HCV envelope glycoproteins when adjuvanted with cyclic-di-AMP, a STING activator or archaeosomes
2017 StandoutNobel
mRNA-LNP expressing PfCSP and Pfs25 vaccine candidates targeting infection and transmission of Plasmodium falciparum
2022 StandoutNobel
High loading efficiency and sustained release of siRNA encapsulated in PLGA nanoparticles: Quality by design optimization and characterization
2010
Biomedical applications of biodegradable polymers
2011 Standout
Particle Size Influences the Immune Response Produced by Hepatitis B Vaccine Formulated in Inhalable Particles
2010
mRNA vaccines for infectious diseases: principles, delivery and clinical translation
2021 StandoutNobel
PLGA-dendron nanoparticles enhance immunogenicity but not lethal antibody production of a DNA vaccine against anthrax in mice
2006
Delivery technologies for cancer immunotherapy
2019 Standout
Efficacy of an Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults
2015 Standout
The use of self-adjuvanting nanofiber vaccines to elicit high-affinity B cell responses to peptide antigens without inflammation
2013
Synthetic Double-Stranded RNAs Are Adjuvants for the Induction of T Helper 1 and Humoral Immune Responses to Human Papillomavirus in Rhesus Macaques
2009 StandoutNobel
Biodegradable polymeric nanoparticles based drug delivery systems
2009 Standout
Spatio-temporal control strategy of drug delivery systems based nano structures
2017
Vaccine adjuvants – understanding molecular mechanisms to improve vaccines
2014 StandoutNobel
Controlled release of amoxicillin from hydroxyapatite-coated poly(lactic-co-glycolic acid) microspheres
2008
A new synthetic TLR4 agonist, GLA, allows dendritic cells targeted with antigen to elicit Th1 T‐cell immunity in vivo
2011 StandoutNobel
Polymeric nanogels as vaccine delivery systems
2012
Strategies in the design of nanoparticles for therapeutic applications
2010 Standout
PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect
2010
A Full-Length Plasmodium falciparum Recombinant Circumsporozoite Protein Expressed by Pseudomonas fluorescens Platform as a Malaria Vaccine Candidate
2014
Vaccine Adjuvant Systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers
2008
The role of inflammasomes in the immunostimulatory effects of particulate vaccine adjuvants
2010
Vaccine manufacturing: challenges and solutions
2006
“Pathogen-Mimicking” Nanoparticles for Vaccine Delivery to Dendritic Cells
2007
Increased surface expression of HIV-1 envelope is associated with improved antibody response in vaccinia prime/protein boost immunization
2017 StandoutNobel
Nano/micro technologies for delivering macromolecular therapeutics using poly(d,l-lactide-co-glycolide) and its derivatives
2007
Vaccine adjuvants revisited
2007
Current advances in research and clinical applications of PLGA-based nanotechnology
2009
Application of polymeric nanoparticles in immunotherapy
2012
Recent Developments of Biodegradable and Biocompatible Materials Based Micro/Nanoparticles for Delivering Macromolecular Therapeutics
2009
Nanoparticles for drug delivery to the lungs
2007
Biomolecular coronas provide the biological identity of nanosized materials
2012 Standout
Shape and size-dependent immune response to antigen-carrying nanoparticles
2015
Engineering of monosized lipid-coated mesoporous silica nanoparticles for CRISPR delivery
2020 StandoutNobel
Development and Characterization of Synthetic Glucopyranosyl Lipid Adjuvant System as a Vaccine Adjuvant
2011
Endocytosis of nanomedicines
2010 Standout
Polymeric Multilayer Capsules in Drug Delivery
2010
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
2014 Standout
Cancer immunotherapy: nanodelivery approaches for immune cell targeting and tracking
2014
Development of Virus-Like Particle Technology from Small Highly Symmetric to Large Complex Virus-Like Particle Structures
2013 Standout
Dendritic cells require a systemic type I interferon response to mature and induce CD4+ Th1 immunity with poly IC as adjuvant
2009 StandoutNobel
Supramolecular biomaterials
2015 Standout
Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer
2018 Standout
Induction of Broad CD4+and CD8+T-Cell Responses and Cross- Neutralizing Antibodies against Hepatitis C Virus by Vaccination with Th1-Adjuvanted Polypeptides Followed by Defective Alphaviral Particles Expressing Envelope Glycoproteins gpE1 and gpE2 and Nonstructural Proteins 3, 4, and 5
2008 StandoutNobel
Vaccine Delivery Methods Using Viral Vectors
2006
Aerosolized PLA and PLGA Nanoparticles Enhance Humoral, Mucosal and Cytokine Responses to Hepatitis B Vaccine
2010
Supramolecular Hydrogelators and Hydrogels: From Soft Matter to Molecular Biomaterials
2015 Standout
pH-Responsive Nanoparticle Vaccines for Dual-Delivery of Antigens and Immunostimulatory Oligonucleotides
2013
Nanoencapsulation, Nano-guard for Pesticides: A New Window for Safe Application
2016 Standout
Nanoparticles and microparticles as vaccine-delivery systems
2007
Nonviral Vectors for Gene Delivery
2008 Standout
Femtosecond Real-Time Probing of Reactions. 23. Studies of Temporal, Velocity, Angular, and State Dynamics from Transition States to Final Products by Femtosecond-Resolved Mass Spectrometry
1998 StandoutNobel
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
2016 Standout
Photofragment imaging by sections for measuring state-resolved angle-velocity differential cross sections
1996
Adjuvant solution for pandemic influenza vaccine production
2012
Universal crossed molecular beams apparatus with synchrotron photoionization mass spectrometric product detection
1997
Encapsulation of Natural Polyphenolic Compounds; a Review
2011 Standout
Stabilization of Tetanus Toxoid Encapsulated in PLGA Microspheres
2008
Synthetic double-stranded RNA induces innate immune responses similar to a live viral vaccine in humans
2011 StandoutNobel
Uptake of particulate vaccine adjuvants by dendritic cells activates the NALP3 inflammasome
2009
Nanoparticles in Photodynamic Therapy
2015 Standout
Vaccine innovations for emerging infectious diseases—a symposium report
2019 StandoutNobel
Degradability and Clearance of Silicon, Organosilica, Silsesquioxane, Silica Mixed Oxide, and Mesoporous Silica Nanoparticles
2017
Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier
2011 Standout
Molecular and cellular signatures of human vaccine adjuvants
2008
Immune correlates of vaccine protection against HIV-1 acquisition
2015
Polydopamine and Its Derivative Materials: Synthesis and Promising Applications in Energy, Environmental, and Biomedical Fields
2014 Standout
Hepatitis C virus polyprotein vaccine formulations capable of inducing broad antibody and cellular immune responses
2006 StandoutNobel
Beyond antigens and adjuvants: formulating future vaccines
2016
Working together: interactions between vaccine antigens and adjuvants
2013
Applying TLR Synergy in Immunotherapy: Implications in Cutaneous Leishmaniasis
2010
Core/Shell Nanoparticles: Classes, Properties, Synthesis Mechanisms, Characterization, and Applications
2011 Standout
Resiquimod and other immune response modifiers as vaccine adjuvants
2007
Measuring ultrashort laser pulses in the time-frequency domain using frequency-resolved optical gating
1997 Standout
Chemically Modified Bacterial Sacculi as a Vaccine Microparticle Scaffold
2022 StandoutNobel
Photothermal Nanomaterials: A Powerful Light-to-Heat Converter
2023 Standout
A Defined Tuberculosis Vaccine Candidate Boosts BCG and Protects Against Multidrug-Resistant Mycobacterium tuberculosis
2010
Nanoparticle vaccines
2013
Works of James Chesko being referenced
An Investigation of the Factors Controlling the Adsorption of Protein Antigens to Anionic PLG Microparticles
2005
Polylactide-Co-Glycolide Microparticles with Surface Adsorbed Antigens as Vaccine Delivery Systems
2005
Anionic microparticles are a potent delivery system for recombinant antigens from Neisseria meningitidis serotype B
2003
Charged polylactide co-glycolide microparticles as antigen delivery systems
2004
Encapsulation of the immune potentiators MPL and RC529 in PLG microparticles enhances their potency
2005
Physicochemical characterization and biological activity of synthetic TLR4 agonist formulations
2009
The potency of the adjuvant, CpG oligos, is enhanced by encapsulation in PLG microparticles
2007
Adsorption of a Novel Recombinant Glycoprotein from HIV (Env gp120dV2 SF162) to Anionic PLG Microparticles Retains the Structural Integrity of the Protein, Whereas Encapsulation in PLG Microparticles Does Not
2004
A preliminary evaluation of alternative adjuvants to alum using a range of established and new generation vaccine antigens
2005
A comparison of anionic nanoparticles and microparticles as vaccine delivery systems
2008
Characterization of antigens adsorbed to anionic PLG microparticles by XPS and TOF‐SIMS
2007
A Practical Approach to the use of Nanoparticles for Vaccine Delivery
2006
Adjuvanted pandemic influenza vaccine: variation of emulsion components affects stability, antigen structure, and vaccine efficacy
2012
Photodissociation of ozone at 193 nm by high-resolution photofragment translational spectroscopy
1995